What is CG Oncology's investment purchases?

CG Oncology (CGON) reported investment purchases of $587.39M in Q1 2026.

How has CG Oncology's investment purchases changed year-over-year?

CG Oncology's investment purchases increased by 62.3% year-over-year, from $361.89M to $587.39M.

What is the long-term trend for CG Oncology's investment purchases?

Over 2 years (2023 to 2025), CG Oncology's investment purchases has grown at a 43.6% compound annual growth rate (CAGR), from $517.61M to $1.07B.

What does investment purchases mean?

Cash spent purchasing investment securities across all categories.

CG Oncology CGON Investment Purchases

Investment Purchases at other companies

Johnson & JohnsonJNJ

$144M-42.6%

Gilead SciencesGILD

$525M—

ImmunityBio, Inc.IBRX

$139.09M+138,993%

CelcuityCELC

$15.2M-64.2%

Summit TherapeuticsSMMT

$177.29M—

BiogenBIIB

$748.8M—

Other financials

Income statement

See full

Revenue$1.1M+1,983%

Operating income-$66.4M-57.3%

Net income-$60.2M-74.7%

EPS (diluted)-$0.71-57.8%

Balance sheet

See full

Cash & equivalents$33.7M-18.7%

Total debt$7.6M+631%

Total equity$1.1B+54.9%

Total assets$1.1B+55.9%

Cash flow

See full

Operating cash flow-$56.9M-94.5%

CapEx$304.0K+1,800%

Free cash flow-$57.2M-95.4%

Valuation

See full

Market cap$5.8B+206%

Profitability

See full

Operating margin-4,239%-1,872pp

Net margin-3,682.6%-1,601pp

FCF margin-3,163.8%-1,351pp

Returns & leverage

See full

Return on equity-20.8%+7.1pp

Debt / equity0×0.0×

Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireInvestments.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CG Oncology's investment purchases?: CG Oncology (CGON) reported investment purchases of $587.39M in Q1 2026.
How has CG Oncology's investment purchases changed year-over-year?: CG Oncology's investment purchases increased by 62.3% year-over-year, from $361.89M to $587.39M.
What is the long-term trend for CG Oncology's investment purchases?: Over 2 years (2023 to 2025), CG Oncology's investment purchases has grown at a 43.6% compound annual growth rate (CAGR), from $517.61M to $1.07B.
What does investment purchases mean?: Cash spent purchasing investment securities across all categories.